Learn more about our Ethylene Oxide & Sterilization work.
By Friday, March 1, the Environmental Protection Agency is expected to finalize its regulation for the ethylene oxide (EtO) sterilization of 20 billion, or half, of all medical devices in…
In testimony today before the U.S. House of Representatives Committee on Small Business, Dr. Lishan Aklog urged Congress and the executive branch to consider the dire consequences for patients and…
In testimony today before a key congressional subcommittee hearing, AdvaMed, the Medtech Association, called for a balance in the proposed regulations of the method used to sterilize 20 billion, or…
Scott Whitaker, president and CEO of AdvaMed, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of…
Ethylene oxide sterilization ensures billions of pieces of medical technology are sterile for patients in every medical setting, in surgical procedures from c-sections to knee replacements.
According to a senior toxicologist in a RealClearPolicy op-ed, the EPA draws unreasonable conclusions about the health risks of the ethylene oxide used to sterilize medical technology.
In comments filed with the Environment Protection Agency (EPA) today, AdvaMed, the Medtech Association, called for continued cooperation between the industry and the agency as the regulations covering medical device…
AdvaMed, the Medtech Association, today welcomed the U.S. Environmental Protection Agency (EPA) extension of 15 more days for public comment on two proposed updates to regulations governing the use of…
AdvaMed, the Medtech Association, urges the Environmental Protection Agency (EPA) to heed concerns of medtech supply shortfalls under its proposed requirements on ethylene oxide (EtO) sterilization and consider the effects…
AdvaMed: “We place the highest priority on the safety of our communities, employees, and the millions of patients we serve.” WASHINGTON, D.C. – This week, medtech leaders from across the country…